Cancers (Aug 2021)

Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer

  • Darren Kilmartin,
  • Mark O’Loughlin,
  • Xavier Andreu,
  • Zsuzsanna Bagó-Horváth,
  • Simonetta Bianchi,
  • Ewa Chmielik,
  • Gábor Cserni,
  • Paulo Figueiredo,
  • Giuseppe Floris,
  • Maria Pia Foschini,
  • Anikó Kovács,
  • Päivi Heikkilä,
  • Janina Kulka,
  • Anne-Vibeke Laenkholm,
  • Inta Liepniece-Karele,
  • Caterina Marchiò,
  • Elena Provenzano,
  • Peter Regitnig,
  • Angelika Reiner,
  • Aleš Ryška,
  • Anna Sapino,
  • Elisabeth Specht Stovgaard,
  • Cecily Quinn,
  • Vasiliki Zolota,
  • Mark Webber,
  • Davood Roshan,
  • Sharon A. Glynn,
  • Grace Callagy

DOI
https://doi.org/10.3390/cancers13174410
Journal volume & issue
Vol. 13, no. 17
p. 4410

Abstract

Read online

Stromal tumour infiltrating lymphocytes (sTILs) are a strong prognostic marker in triple negative breast cancer (TNBC). Consistency scoring sTILs is good and was excellent when an internet-based scoring aid developed by the TIL-WG was used to score cases in a reproducibility study. This study aimed to evaluate the reproducibility of sTILs assessment using this scoring aid in cases from routine practice and to explore the potential of the tool to overcome variability in scoring. Twenty-three breast pathologists scored sTILs in digitized slides of 49 TNBC biopsies using the scoring aid. Subsequently, fields of view (FOV) from each case were selected by one pathologist and scored by the group using the tool. Inter-observer agreement was good for absolute sTILs (ICC 0.634, 95% CI 0.539–0.735, p p p p < 0.001) cutpoints. However, there was a wide range of scores for many cases. Reproducibility scoring sTILs is good when the scoring aid is used. Heterogeneity is the main contributor to variance and will need to be overcome for analytic validity to be achieved.

Keywords